Business
Single-shot Johnson & Johnson vaccine 66 per cent effective against COVID-19, study shows – The Age
The company says its vaccine is 72 per cent effective in preventing COVID-19 in the US but a lower rate of 66 per cent was observed globally in the large trial…
J&J plans to seek emergency use authorisation in the US within a week. It expects to supply 100 million doses to the US by June and a billion doses globally by years end but declined to say how much could be ready if the Food and Drug Administration gives the green light.
Defeating the scourge that has killed more than 2 million people worldwide will require vaccinating billions. The shots being rolled out in different countries so far all require two doses a few weeks apart for full protection….
-
Noosa News23 hours agoBali traveller sparks urgent measles alert across Queensland
-
Noosa News23 hours agoQueensland man sentenced to four years imprisonment after string of terror offences
-
Business23 hours agoThe best ASX ETFs for compounding wealth until 2040
-
Noosa News21 hours agoMeasles alert issued south of Brisbane after traveller tests positive